APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amino Acid Metabolism Disorder Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Amino Acid Metabolism Disorder Drug Market Analysis and Forecast 2026-2032

19 December 2025195 pages

Choose your research edition.

Industry ResearchAmino Acid Metabolism Disorder Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Amino Acid Metabolism Disorder Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Amino Acid Metabolism Disorder Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amino Acid Metabolism Disorder Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Amino Acid Metabolism Disorder Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Amino Acid Metabolism Disorder Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Amino Acid Metabolism Disorder Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Amino Acid Metabolism Disorder Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Amino Acid Metabolism Disorder Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Amino Acid Metabolism Disorder Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Amino Acid Metabolism Disorder Drug include AMINO, BioMarin, DSM, Kyowa Hakko Kirin, Recordati, Shine Star (Hubei) Biological Engineering, Swedish Orphan Biovitrum, GlaxoSmithKline and Pfizer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Amino Acid Metabolism Disorder Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Amino Acid Metabolism Disorder Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Amino Acid Metabolism Disorder Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Amino Acid Metabolism Disorder Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Amino Acid Metabolism Disorder Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Amino Acid Metabolism Disorder Drug revenue, projected growth trends, production technology, application and end-user industry.

Amino Acid Metabolism Disorder Drug Segment by Company

AMINO

BioMarin

DSM

Kyowa Hakko Kirin

Recordati

Shine Star (Hubei) Biological Engineering

Swedish Orphan Biovitrum

GlaxoSmithKline

Pfizer

Merck

Sanofi

Amino Acid Metabolism Disorder Drug Segment by Type

Folic Acid

Sapropterin Dihydrochloride

Vitamin D

Vitamin B6 & B12

Betaine

Thiamine

Carglumic Acid

Arginine

Others

Amino Acid Metabolism Disorder Drug Segment by Application

Argininosuccinic Acidemia

Citrullinemia

Homocystinuria

Maple Syrup Urine Disease

Phenylketonuria

Amino Acid Metabolism Disorder Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amino Acid Metabolism Disorder Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amino Acid Metabolism Disorder Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amino Acid Metabolism Disorder Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Amino Acid Metabolism Disorder Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Amino Acid Metabolism Disorder Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amino Acid Metabolism Disorder Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Folic Acid Major Player Table 3. Sapropterin Dihydrochloride Major Player Table 4. Vitamin D Major Player Table 5. Vitamin B6 & B12 Major Player Table 6. Betaine Major Player Table 7. Thiamine Major Player Table 8. Carglumic Acid Major Player Table 9. Arginine Major Player Table 10. Others Major Player Table 11. Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 12. Argininosuccinic Acidemia Major Player Table 13. Citrullinemia Major Player Table 14. Homocystinuria Major Player Table 15. Maple Syrup Urine Disease Major Player Table 16. Phenylketonuria Major Player Table 17. Amino Acid Metabolism Disorder Drug Industry Trends Table 18. Amino Acid Metabolism Disorder Drug Industry Drivers Table 19. Amino Acid Metabolism Disorder Drug Industry Opportunities and Challenges Table 20. Amino Acid Metabolism Disorder Drug Industry Restraints Table 21. Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 22. Global Amino Acid Metabolism Disorder Drug Market Size by Region (2021-2026) & (US$ Million) Table 23. Global Amino Acid Metabolism Disorder Drug Market Share by Region (2021-2026) Table 24. Global Amino Acid Metabolism Disorder Drug Market Size by Region (2027-2032) & (US$ Million) Table 25. Global Amino Acid Metabolism Disorder Drug Market Share by Region (2027-2032) Table 26. Global Amino Acid Metabolism Disorder Drug Revenue by Players (US$ Million) & (2021-2026) Table 27. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Players (2021-2026) Table 28. Global Amino Acid Metabolism Disorder Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 29. Global Amino Acid Metabolism Disorder Drug Key Players Headquarters & Area Served Table 30. Global Amino Acid Metabolism Disorder Drug Players, Product Type & Application Table 31. Global Amino Acid Metabolism Disorder Drug Players Establishment Date Table 32. Global Players Market Concentration Ratio (CR5 and HHI) Table 33. Global Amino Acid Metabolism Disorder Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Amino Acid Metabolism Disorder Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Amino Acid Metabolism Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2021-2026) Table 38. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2027-2032) Table 39. Global Amino Acid Metabolism Disorder Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 41. Global Amino Acid Metabolism Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 42. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2021-2026) Table 43. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2027-2032) Table 44. AMINO Company Information Table 45. AMINO Business Overview Table 46. AMINO Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. AMINO Amino Acid Metabolism Disorder Drug Product Portfolio Table 48. AMINO Recent Development Table 49. BioMarin Company Information Table 50. BioMarin Business Overview Table 51. BioMarin Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. BioMarin Amino Acid Metabolism Disorder Drug Product Portfolio Table 53. BioMarin Recent Development Table 54. DSM Company Information Table 55. DSM Business Overview Table 56. DSM Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. DSM Amino Acid Metabolism Disorder Drug Product Portfolio Table 58. DSM Recent Development Table 59. Kyowa Hakko Kirin Company Information Table 60. Kyowa Hakko Kirin Business Overview Table 61. Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Product Portfolio Table 63. Kyowa Hakko Kirin Recent Development Table 64. Recordati Company Information Table 65. Recordati Business Overview Table 66. Recordati Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Recordati Amino Acid Metabolism Disorder Drug Product Portfolio Table 68. Recordati Recent Development Table 69. Shine Star (Hubei) Biological Engineering Company Information Table 70. Shine Star (Hubei) Biological Engineering Business Overview Table 71. Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Product Portfolio Table 73. Shine Star (Hubei) Biological Engineering Recent Development Table 74. Swedish Orphan Biovitrum Company Information Table 75. Swedish Orphan Biovitrum Business Overview Table 76. Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Product Portfolio Table 78. Swedish Orphan Biovitrum Recent Development Table 79. GlaxoSmithKline Company Information Table 80. GlaxoSmithKline Business Overview Table 81. GlaxoSmithKline Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. GlaxoSmithKline Amino Acid Metabolism Disorder Drug Product Portfolio Table 83. GlaxoSmithKline Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Pfizer Amino Acid Metabolism Disorder Drug Product Portfolio Table 88. Pfizer Recent Development Table 89. Merck Company Information Table 90. Merck Business Overview Table 91. Merck Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Merck Amino Acid Metabolism Disorder Drug Product Portfolio Table 93. Merck Recent Development Table 94. Sanofi Company Information Table 95. Sanofi Business Overview Table 96. Sanofi Amino Acid Metabolism Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Sanofi Amino Acid Metabolism Disorder Drug Product Portfolio Table 98. Sanofi Recent Development Table 99. North America Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 100. North America Amino Acid Metabolism Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 101. North America Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 102. North America Amino Acid Metabolism Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 103. North America Amino Acid Metabolism Disorder Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Amino Acid Metabolism Disorder Drug Revenue by Country (2021-2026) & (US$ Million) Table 105. North America Amino Acid Metabolism Disorder Drug Revenue by Country (US$ Million) & (2027-2032) Table 106. Europe Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 107. Europe Amino Acid Metabolism Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 108. Europe Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 109. Europe Amino Acid Metabolism Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 110. Europe Amino Acid Metabolism Disorder Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe Amino Acid Metabolism Disorder Drug Revenue by Country (2021-2026) & (US$ Million) Table 112. Europe Amino Acid Metabolism Disorder Drug Revenue by Country (US$ Million) & (2027-2032) Table 113. China Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 114. China Amino Acid Metabolism Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 115. China Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 116. China Amino Acid Metabolism Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 117. Asia Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 118. Asia Amino Acid Metabolism Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 119. Asia Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 120. Asia Amino Acid Metabolism Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 121. Asia Amino Acid Metabolism Disorder Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Asia Amino Acid Metabolism Disorder Drug Revenue by Region (US$ Million) & (2021-2026) Table 123. Asia Amino Acid Metabolism Disorder Drug Revenue by Region (US$ Million) & (2027-2032) Table 124. SAMEA Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2026) & (US$ Million) Table 125. SAMEA Amino Acid Metabolism Disorder Drug Revenue by Type (2027-2032) & (US$ Million) Table 126. SAMEA Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2026) & (US$ Million) Table 127. SAMEA Amino Acid Metabolism Disorder Drug Revenue by Application (2027-2032) & (US$ Million) Table 128. SAMEA Amino Acid Metabolism Disorder Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. SAMEA Amino Acid Metabolism Disorder Drug Revenue by Country (2021-2026) & (US$ Million) Table 130. SAMEA Amino Acid Metabolism Disorder Drug Revenue by Country (US$ Million) & (2027-2032) Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Amino Acid Metabolism Disorder Drug Image Figure 2. Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amino Acid Metabolism Disorder Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Folic Acid Image Figure 5. Sapropterin Dihydrochloride Image Figure 6. Vitamin D Image Figure 7. Vitamin B6 & B12 Image Figure 8. Betaine Image Figure 9. Thiamine Image Figure 10. Carglumic Acid Image Figure 11. Arginine Image Figure 12. Others Image Figure 13. Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Amino Acid Metabolism Disorder Drug Market Size Share 2021 VS 2025 VS 2032 Figure 15. Argininosuccinic Acidemia Image Figure 16. Citrullinemia Image Figure 17. Homocystinuria Image Figure 18. Maple Syrup Urine Disease Image Figure 19. Phenylketonuria Image Figure 20. Global Amino Acid Metabolism Disorder Drug Market Size (US$ Million) & (2021-2032) Figure 21. Global Amino Acid Metabolism Disorder Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 22. Global Amino Acid Metabolism Disorder Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 23. Global Amino Acid Metabolism Disorder Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 24. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Global Amino Acid Metabolism Disorder Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Amino Acid Metabolism Disorder Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2021-2032) Figure 28. Global Amino Acid Metabolism Disorder Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 30. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2021-2032) Figure 31. North America Amino Acid Metabolism Disorder Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. North America Amino Acid Metabolism Disorder Drug Revenue Share by Type (2021-2032) Figure 33. North America Amino Acid Metabolism Disorder Drug Revenue Share by Application (2021-2032) Figure 34. North America Amino Acid Metabolism Disorder Drug Revenue Share by Country (2021-2032) Figure 35. United States Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Canada Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Mexico Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Europe Amino Acid Metabolism Disorder Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 39. Europe Amino Acid Metabolism Disorder Drug Revenue Share by Type (2021-2032) Figure 40. Europe Amino Acid Metabolism Disorder Drug Revenue Share by Application (2021-2032) Figure 41. Europe Amino Acid Metabolism Disorder Drug Revenue Share by Country (2021-2032) Figure 42. Germany Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. France Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. U.K. Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Italy Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Spain Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. Russia Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. Netherlands Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. Nordic Countries Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. China Amino Acid Metabolism Disorder Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 51. China Amino Acid Metabolism Disorder Drug Revenue Share by Type (2021-2032) Figure 52. China Amino Acid Metabolism Disorder Drug Revenue Share by Application (2021-2032) Figure 53. Asia Amino Acid Metabolism Disorder Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. Asia Amino Acid Metabolism Disorder Drug Revenue Share by Type (2021-2032) Figure 55. Asia Amino Acid Metabolism Disorder Drug Revenue Share by Application (2021-2032) Figure 56. Asia Amino Acid Metabolism Disorder Drug Revenue Share by Region (2021-2032) Figure 57. Japan Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. South Korea Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. India Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Australia Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Taiwan Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Southeast Asia Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. SAMEA Amino Acid Metabolism Disorder Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 64. SAMEA Amino Acid Metabolism Disorder Drug Revenue Share by Type (2021-2032) Figure 65. SAMEA Amino Acid Metabolism Disorder Drug Revenue Share by Application (2021-2032) Figure 66. SAMEA Amino Acid Metabolism Disorder Drug Revenue Share by Country (2021-2032) Figure 67. Brazil Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Argentina Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Chile Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Colombia Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Peru Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Saudi Arabia Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Israel Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. UAE Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Turkey Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 76. Iran Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 77. Egypt Amino Acid Metabolism Disorder Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • Folic Acid
  • Sapropterin Dihydrochloride
  • Vitamin D
  • Vitamin B6 & B12
  • Betaine
  • Thiamine
  • Carglumic Acid
  • Arginine
  • Others
Applications
  • Argininosuccinic Acidemia
  • Citrullinemia
  • Homocystinuria
  • Maple Syrup Urine Disease
  • Phenylketonuria
Companies covered
  • AMINO
  • BioMarin
  • DSM
  • Kyowa Hakko Kirin
  • Recordati
  • Shine Star (Hubei) Biological Engineering
  • Swedish Orphan Biovitrum
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Amino Acid Metabolism Disorder Drug Market by Type
  3. 1.2.1 Global Amino Acid Metabolism Disorder Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Folic Acid
  5. 1.2.3 Sapropterin Dihydrochloride
  6. 1.2.4 Vitamin D
  7. 1.2.5 Vitamin B6 & B12
  8. 1.2.6 Betaine
  9. 1.2.7 Thiamine
  10. 1.2.8 Carglumic Acid
  11. 1.2.9 Arginine
  12. 1.2.10 Others
  13. 1.3 Amino Acid Metabolism Disorder Drug Market by Application
  14. 1.3.1 Global Amino Acid Metabolism Disorder Drug Market Size by Application, 2021 VS 2025 VS 2032
  15. 1.3.2 Argininosuccinic Acidemia
  16. 1.3.3 Citrullinemia
  17. 1.3.4 Homocystinuria
  18. 1.3.5 Maple Syrup Urine Disease
  19. 1.3.6 Phenylketonuria
  20. 1.4 Assumptions and Limitations
  21. 1.5 Study Goals and Objectives
2 Amino Acid Metabolism Disorder Drug Market Dynamics
  1. 2.1 Amino Acid Metabolism Disorder Drug Industry Trends
  2. 2.2 Amino Acid Metabolism Disorder Drug Industry Drivers
  3. 2.3 Amino Acid Metabolism Disorder Drug Industry Opportunities and Challenges
  4. 2.4 Amino Acid Metabolism Disorder Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Amino Acid Metabolism Disorder Drug Market Perspective (2021-2032)
  2. 3.2 Global Amino Acid Metabolism Disorder Drug Growth Trends by Region
  3. 3.2.1 Global Amino Acid Metabolism Disorder Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Amino Acid Metabolism Disorder Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Amino Acid Metabolism Disorder Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Amino Acid Metabolism Disorder Drug Revenue by Players
  2. 4.1.1 Global Amino Acid Metabolism Disorder Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Amino Acid Metabolism Disorder Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Amino Acid Metabolism Disorder Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Amino Acid Metabolism Disorder Drug Key Players Headquarters & Area Served
  7. 4.4 Global Amino Acid Metabolism Disorder Drug Players, Product Type & Application
  8. 4.5 Global Amino Acid Metabolism Disorder Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Amino Acid Metabolism Disorder Drug Market CR5 and HHI
  11. 4.6.3 2025 Amino Acid Metabolism Disorder Drug Tier 1, Tier 2, and Tier 3
5 Amino Acid Metabolism Disorder Drug Market Size by Type
  1. 5.1 Global Amino Acid Metabolism Disorder Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2032)
  3. 5.3 Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2021-2032)
6 Amino Acid Metabolism Disorder Drug Market Size by Application
  1. 6.1 Global Amino Acid Metabolism Disorder Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2032)
  3. 6.3 Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AMINO
  2. 7.1.1 AMINO Company Information
  3. 7.1.2 AMINO Business Overview
  4. 7.1.3 AMINO Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AMINO Amino Acid Metabolism Disorder Drug Product Portfolio
  6. 7.1.5 AMINO Recent Developments
  7. 7.2 BioMarin
  8. 7.2.1 BioMarin Company Information
  9. 7.2.2 BioMarin Business Overview
  10. 7.2.3 BioMarin Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BioMarin Amino Acid Metabolism Disorder Drug Product Portfolio
  12. 7.2.5 BioMarin Recent Developments
  13. 7.3 DSM
  14. 7.3.1 DSM Company Information
  15. 7.3.2 DSM Business Overview
  16. 7.3.3 DSM Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 DSM Amino Acid Metabolism Disorder Drug Product Portfolio
  18. 7.3.5 DSM Recent Developments
  19. 7.4 Kyowa Hakko Kirin
  20. 7.4.1 Kyowa Hakko Kirin Company Information
  21. 7.4.2 Kyowa Hakko Kirin Business Overview
  22. 7.4.3 Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Product Portfolio
  24. 7.4.5 Kyowa Hakko Kirin Recent Developments
  25. 7.5 Recordati
  26. 7.5.1 Recordati Company Information
  27. 7.5.2 Recordati Business Overview
  28. 7.5.3 Recordati Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Recordati Amino Acid Metabolism Disorder Drug Product Portfolio
  30. 7.5.5 Recordati Recent Developments
  31. 7.6 Shine Star (Hubei) Biological Engineering
  32. 7.6.1 Shine Star (Hubei) Biological Engineering Company Information
  33. 7.6.2 Shine Star (Hubei) Biological Engineering Business Overview
  34. 7.6.3 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Product Portfolio
  36. 7.6.5 Shine Star (Hubei) Biological Engineering Recent Developments
  37. 7.7 Swedish Orphan Biovitrum
  38. 7.7.1 Swedish Orphan Biovitrum Company Information
  39. 7.7.2 Swedish Orphan Biovitrum Business Overview
  40. 7.7.3 Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Product Portfolio
  42. 7.7.5 Swedish Orphan Biovitrum Recent Developments
  43. 7.8 GlaxoSmithKline
  44. 7.8.1 GlaxoSmithKline Company Information
  45. 7.8.2 GlaxoSmithKline Business Overview
  46. 7.8.3 GlaxoSmithKline Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  47. 7.8.4 GlaxoSmithKline Amino Acid Metabolism Disorder Drug Product Portfolio
  48. 7.8.5 GlaxoSmithKline Recent Developments
  49. 7.9 Pfizer
  50. 7.9.1 Pfizer Company Information
  51. 7.9.2 Pfizer Business Overview
  52. 7.9.3 Pfizer Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Pfizer Amino Acid Metabolism Disorder Drug Product Portfolio
  54. 7.9.5 Pfizer Recent Developments
  55. 7.10 Merck
  56. 7.10.1 Merck Company Information
  57. 7.10.2 Merck Business Overview
  58. 7.10.3 Merck Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Merck Amino Acid Metabolism Disorder Drug Product Portfolio
  60. 7.10.5 Merck Recent Developments
  61. 7.11 Sanofi
  62. 7.11.1 Sanofi Company Information
  63. 7.11.2 Sanofi Business Overview
  64. 7.11.3 Sanofi Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Sanofi Amino Acid Metabolism Disorder Drug Product Portfolio
  66. 7.11.5 Sanofi Recent Developments
8 North America
  1. 8.1 North America Amino Acid Metabolism Disorder Drug Revenue (2021-2032)
  2. 8.2 North America Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Amino Acid Metabolism Disorder Drug Revenue by Type (2027-2032)
  5. 8.3 North America Amino Acid Metabolism Disorder Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Amino Acid Metabolism Disorder Drug Revenue by Application (2027-2032)
  9. 8.5 North America Amino Acid Metabolism Disorder Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Amino Acid Metabolism Disorder Drug Revenue by Country
  11. 8.6.1 North America Amino Acid Metabolism Disorder Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Amino Acid Metabolism Disorder Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Amino Acid Metabolism Disorder Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Amino Acid Metabolism Disorder Drug Revenue (2021-2032)
  2. 9.2 Europe Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Amino Acid Metabolism Disorder Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Amino Acid Metabolism Disorder Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Amino Acid Metabolism Disorder Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Amino Acid Metabolism Disorder Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Amino Acid Metabolism Disorder Drug Revenue by Country
  11. 9.6.1 Europe Amino Acid Metabolism Disorder Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Amino Acid Metabolism Disorder Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Amino Acid Metabolism Disorder Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Amino Acid Metabolism Disorder Drug Revenue (2021-2032)
  2. 10.2 China Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Amino Acid Metabolism Disorder Drug Revenue by Type (2027-2032)
  5. 10.3 China Amino Acid Metabolism Disorder Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Amino Acid Metabolism Disorder Drug Revenue by Application (2027-2032)
  9. 10.5 China Amino Acid Metabolism Disorder Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Amino Acid Metabolism Disorder Drug Revenue (2021-2032)
  2. 11.2 Asia Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Amino Acid Metabolism Disorder Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Amino Acid Metabolism Disorder Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Amino Acid Metabolism Disorder Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Amino Acid Metabolism Disorder Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Amino Acid Metabolism Disorder Drug Revenue by Country
  11. 11.6.1 Asia Amino Acid Metabolism Disorder Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Amino Acid Metabolism Disorder Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Amino Acid Metabolism Disorder Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Amino Acid Metabolism Disorder Drug Revenue (2021-2032)
  2. 12.2 SAMEA Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Amino Acid Metabolism Disorder Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Amino Acid Metabolism Disorder Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Amino Acid Metabolism Disorder Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Amino Acid Metabolism Disorder Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Amino Acid Metabolism Disorder Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Amino Acid Metabolism Disorder Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Amino Acid Metabolism Disorder Drug Revenue by Country
  11. 12.6.1 SAMEA Amino Acid Metabolism Disorder Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Amino Acid Metabolism Disorder Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Amino Acid Metabolism Disorder Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst